A copper-binding peptide the body makes on its own. The literature on it centres on collagen and the extracellular matrix, which is why we reach for it when connective tissue is the bottleneck in someone’s recovery.
Our Expertise
GHK-Cu is short for Glycyl-L-Histidyl-L-Lysine copper. Your own plasma, saliva and urine contain it already — this is not a foreign compound. Published work has looked at what it does in tissue remodelling, wound repair and cellular regeneration.
We consider it where the limiting factor is connective tissue: soft-tissue repair that has stalled, collagen quality, joint and tendon health, remodelling after an injury, or an inflammatory load that will not settle.
The proposed mechanisms in the literature are collagen and extracellular-matrix production, wound-healing pathways, inflammatory signalling, and gene expression tied to repair. We want to be straight with you: this is an active research area, not settled science.
Nobody here will hand you GHK-Cu as a standalone fix. It is dosed to you, monitored by a physician, and it sits alongside the rehabilitation work — it does not replace it.
How It Works
A physician reviews your history, goals and labs where indicated to determine whether a GHK-Cu protocol is appropriate for you.
You receive dosing, administration and timeline in plain language, coordinated with any injection, shockwave or rehabilitation work already underway.
Progress is reviewed and the protocol adjusted. Peptides work best inside a coordinated plan, not on their own.
Conditions Treated
Patient Guide & Answers
GHK-Cu is a copper-binding peptide your body already makes — it is present in plasma, saliva and urine. Published work examines what it does in tissue remodelling, wound repair and cellular regeneration.
We consider it where connective tissue is the bottleneck — repair that has stalled, collagen quality, tendon and joint health, remodelling after injury, or inflammation that will not settle.
Peptide programs start at $249 per month. Your exact protocol and cost are set at consultation based on your goals.
Yes. Every protocol is prescribed and monitored by our physicians, and compounds are sourced from licensed U.S. 503A/503B pharmacies.
Candidacy depends on your medical history, medications and goals. Some patients are not appropriate for peptide therapy, and our physicians will tell you honestly at consultation.
If you are dealing with chronic soft-tissue discomfort or delayed recovery, book a consultation to find out whether a GHK-Cu protocol fits your plan.
Important Medical Information
None of the therapies described are FDA-approved to treat, cure or prevent any disease or condition, and they are not a substitute for indicated surgical care. Composition and mechanism characteristics are drawn from published literature and supplier documentation, not from RegenOrtho Palm Beach outcomes. Cellular products are HCT/Ps from accredited U.S. suppliers; per 21 C.F.R. § 1271.3(d) cell factors such as RPA are not classified as HCT/Ps. Donors are U.S.-based, screened and tested by third-party CLIA laboratories. Individual results vary and no outcome is guaranteed. This material is general education, not medical advice. Services are self-pay and are not covered by insurance or Medicare.
